These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2733311)

  • 1. [Value of echocardiography and amplified atrial vectorcardiography for selecting the methods of therapy and prevention of paroxysmal atrial fibrillation].
    Lozinskiĭ LG; Zamotaev IP; Kerimova RE; Gurfinke'l IuI; Gvindzhiliia TV
    Kardiologiia; 1989 Jan; 29(1):40-4. PubMed ID: 2733311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [State of the atrial myocardium in patients with paroxysmal form of fibrillation arrhythmia].
    Zamotaev IP; Lozinskiĭ LG; Kerimova RE; Gvindzhiliia TV
    Kardiologiia; 1990 Oct; 30(10):83-5. PubMed ID: 2290280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of echo- and vectorcardiographic studies of the heart atrium in the assessment of intracardiac hemodynamics and myocardial contractility].
    Lozinskiĭ LG; Zamotaev IP; Kerimova RE; Gvindzhiliia TV
    Kardiologiia; 1990 Aug; 30(8):30-4. PubMed ID: 2255137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of the atrial vectorcardiogram in evaluating the myocardial functional state in ischemic heart disease].
    Lozinskii LG; Zamotaev IP; Fitileva LM; Alekian BG
    Kardiologiia; 1979 Apr; 19(4):30-6. PubMed ID: 439607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential drug therapy and prevention of different types of atrial fibrillation in ischemic heart disease patients].
    Lozinskiĭ LG
    Kardiologiia; 1986 Nov; 26(11):51-5. PubMed ID: 3807128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between efficacy of antiarrhythmic drug therapy and structural remodeling in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Okumura K
    J Cardiol; 2005 Dec; 46(6):229-36. PubMed ID: 16389742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
    Podrid PJ
    Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Programmed esophageal stimulation of the atrium and the long-term effects of anti-arrhythmia therapy of atrial fibrillation and flutter].
    Novotný E; Uhrová V; Suda J
    Vnitr Lek; 1995 Sep; 41(9):586-9. PubMed ID: 7483347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Cosío FG
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):677; author reply 677. PubMed ID: 15946374
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation].
    Rakhmatullov FK; Klimova SV; Rudakova LE; Pchelinsteva SA; Rakhmatullov AF; Khodakova AI
    Klin Med (Mosk); 2012; 90(10):31-4. PubMed ID: 23285759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain rate imaging for noninvasive functional quantification of the left atrium in hypertensive patients with paroxysmal atrial fibrillation.
    Wang Z; Tan H; Zhong M; Jiang G; Zhang Y; Zhang W
    Cardiology; 2008; 109(1):15-24. PubMed ID: 17627105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of trans-esophageal cardiac electric stimulation in the evaluation of anti-arrhythmia therapy in patients with paroxysms of atrial fibrillation and atrial flutter].
    Tatarchenko IP; Oleĭnikov VE; Rakhmatullov FK
    Kardiologiia; 1990 Jul; 30(7):98-9. PubMed ID: 2232478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
    Bellandi F; Dabizzi RP; Mugnaioni G; Cantini F; Palchetti R
    G Ital Cardiol; 1997 Oct; 27(10):1029-35. PubMed ID: 9410773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pilsicainide on dominant frequency in the right and left atria and pulmonary veins during atrial fibrillation: association with its atrial fibrillation terminating effect.
    Horiuchi D; Iwasa A; Sasaki K; Owada S; Kimura M; Sasaki S; Okumura K
    Eur J Pharmacol; 2009 Apr; 608(1-3):54-61. PubMed ID: 19268659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
    Dan GA; Gonţa A
    Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the effectiveness of cordaron in different types of arrhythmia].
    Zakharov VN; Kuznetsov KK
    Kardiologiia; 1977 Apr; 17(4):90-3. PubMed ID: 69743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.